
1. infect immun. 2016 sep 19;84(10):2974-81. doi: 10.1128/iai.00187-16. print 2016
oct.

pyrimidine pathway-dependent -independent functions toxoplasma gondii 
mitochondrial dihydroorotate dehydrogenase.

hortua triana ma(1), cajiao herrera d(2), zimmermann bh(2), fox ba(1), bzik
dj(3).

author information: 
(1)department microbiology immunology, geisel school medicine at
dartmouth, lebanon, new hampshire, usa.
(2)departamento de ciencias biológicas, universidad de los andes, bogotá,
colombia.
(3)department microbiology immunology, geisel school medicine at
dartmouth, lebanon, new hampshire, usa david.j.bzik@dartmouth.edu.

dihydroorotate dehydrogenase (dhodh) mediates fourth step de novo
pyrimidine biosynthesis proven drug target inducing
immunosuppression therapy human disease well rapidly emerging drug 
target treatment malaria. toxoplasma gondii, disruption first,
fifth, sixth step de novo pyrimidine biosynthesis induced uracil
auxotrophy. however, previous attempts generate uracil auxotrophy by
genetically deleting mitochondrion-associated dhodh t. gondii (tgdhodh)
failed. address essentiality tgdhodh, mutant gene alleles
deficient tgdhodh activity designed ablate enzyme activity.
replacement endogenous dhodh gene catalytically deficient dhodh gene 
alleles induced uracil auxotrophy. catalytically deficient tgdhodh localized to
the mitochondria, parasites retained mitochondrial membrane potential. 
results show tgdhodh essential synthesis pyrimidines and
suggest tgdhodh required second essential function independent of
its role pyrimidine biosynthesis.

copyright © 2016, american society microbiology. rights reserved.

doi: 10.1128/iai.00187-16 
pmcid: pmc5038078
pmid: 27481247  [indexed medline]

